Loading...
•
Jun 30
Cardlytics Q2 2025 Earnings Report
Cardlytics announced its financial results for the second quarter ended June 30, 2025, reporting a decrease in revenue and an increase in net loss compared to the same period last year.
Key Takeaways
Cardlytics reported a revenue of $63.2 million for Q2 2025, a 9% decrease year-over-year. The company's net loss widened to $(9.3) million, or $(0.18) per diluted share, from $(4.3) million in Q2 2024. Despite the revenue decline, Adjusted EBITDA turned positive at $2.7 million, up from $(2.3) million in the prior year.
Revenue for Q2 2025 was $63.2 million, marking a 9% decrease year-over-year.
Net Loss significantly increased to $(9.3) million, or $(0.18) per diluted share, compared to $(4.3) million in Q2 2024.
Adjusted EBITDA, a non-GAAP metric, improved to $2.7 million from a loss of $(2.3) million in the same quarter last year.
Monthly Qualified Users (MQUs) grew by 19% year-over-year, reaching 224.5 million.
Cardlytics
Cardlytics
Cardlytics Revenue by Segment
Revenue by Segment
Cardlytics Platform Revenue
CapyFin.comBridg Platform Revenue
CapyFin.com Forward Guidance
For Q3 2025, Cardlytics anticipates Billings to be between $87.0 million and $95.0 million, Revenue between $52.2 million and $58.2 million, Adjusted Contribution between $30.3 million and $34.3 million, and Adjusted EBITDA between $(2.3) million and $2.7 million.
Positive Outlook
- Anticipated positive Adjusted EBITDA range for Q3 2025, with a potential high of $2.7 million.
- Strategic shifts are expected to position the company for long-term profitable growth.
- Doubling down on diversification efforts to navigate headwinds.
- Reinforcing unique network capabilities to strengthen market position.
- Potential for improved Adjusted Contribution compared to the previous year's Q3.
Challenges Ahead
- Forecasted year-over-year decline in Billings for Q3 2025, ranging from (22%) to (15%).
- Expected year-over-year decrease in Revenue for Q3 2025, ranging from (22%) to (13%).
- Anticipated year-over-year decline in Adjusted Contribution for Q3 2025, ranging from (17%) to (6%).
- Adjusted EBITDA guidance includes a potential negative range of $(2.3) million.
- High variability, complexity, and low visibility for certain non-GAAP measures on a forward-looking basis.
Revenue & Expenses
Visualization of income flow from segment revenue to net income